Fournier gangrene medical therapy

Jump to navigation Jump to search

Fournier gangrene Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fournier gangrene from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Lupus and Quality of Life

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fournier gangrene medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fournier gangrene medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Fournier gangrene medical therapy

on Fournier gangrene medical therapy

Fournier gangrene medical therapy in the news

Blogs onFournier gangrene medical therapy

Directions to Hospitals Treating Fournier gangrene

Risk calculators and risk factors for Fournier gangrene medical therapy

Steven C. Campbell, M.D., Ph.D.; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[1]; Jesus Rosario Hernandez, M.D. [2]

Overview

Fournier gangrene is a urological emergency requiring intravenous antibiotics and debridement (surgical removal) of necrotic (dead) tissue. Despite such measures, the mortality rate overall is 40%, but 78% if sepsis is already present at the time of initial hospital admission.[1] The spread of gangrene is rapid at the rate of 2–3 cm/h, hence early diagnosis and emergency surgical treatment is important.[2]

Medical Therapy

Fournier gangrene is a urological emergency requiring intravenous antibiotics and debridement (surgical removal) of necrotic (dead) tissue. Despite such measures, the mortality rate overall is 40%, but 78% if sepsis is already present at the time of initial hospital admission.[1] The spread of gangrene is rapid at the rate of 2–3 cm/h, hence early diagnosis and emergency surgical treatment is important.[2]

Antimicrobial Therapy

  • Fournier gangrene[3]
  • If caused by streptococcus species or clostridia
  • Polymicrobial
  • MRSA (methicillin resistant staphylococcus aureus) suspected

Nutritional Support

The metabolic demands of Fournier gangrene patients are similar to those of other major trauma or burns.[4] Nutritional support to replace lost proteins and fluids from large wounds and/or the result of shock is required from the first day of a patient's hospital admission.

Hyperbaric oxygen

Contraindications to hyperbaric oxygen are:[8][9]

Side effects of hyperbaric oxygen are:

IV γ-globulin

References

  1. 1.0 1.1 Yanar H, Taviloglu K, Ertekin C, Guloglu R, Zorba U, Cabioglu N; et al. (2006). "Fournier's gangrene: risk factors and strategies for management". World J Surg. 30 (9): 1750–4. doi:10.1007/s00268-005-0777-3. PMID 16927060.
  2. 2.0 2.1 Paty R, Smith AD (1992). "Gangrene and Fournier's gangrene". Urol Clin North Am. 19 (1): 149–62. PMID 1736475.
  3. Gilbert, David (2015). The Sanford guide to antimicrobial therapy. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808843.
  4. Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A (2014). "Current concepts in the management of necrotizing fasciitis". Front Surg. 1: 36. doi:10.3389/fsurg.2014.00036. PMC 4286984. PMID 25593960.
  5. Escobar SJ, Slade JB, Hunt TK, Cianci P (2005). "Adjuvant hyperbaric oxygen therapy (HBO2)for treatment of necrotizing fasciitis reduces mortality and amputation rate". Undersea Hyperb Med. 32 (6): 437–43. PMID 16509286.
  6. Korhonen K (2000). "Hyperbaric oxygen therapy in acute necrotizing infections with a special reference to the effects on tissue gas tensions". Ann Chir Gynaecol Suppl (214): 7–36. PMID 11199291.
  7. Hyperbaric oxygen therapy. http://onlinelibrary.wiley.com/doi/10.1080/110241500750008583/abstract (2016) Accessed on September 12, 2016
  8. Kindwall EP, Gottlieb LJ, Larson DL (1991). "Hyperbaric oxygen therapy in plastic surgery: a review article". Plast Reconstr Surg. 88 (5): 898–908. PMID 1924583.
  9. Capelli-Schellpfeffer M, Gerber GS (1999). "The use of hyperbaric oxygen in urology". J Urol. 162 (3 Pt 1): 647–54. PMID 10458334.
  10. Darabi K, Abdel-Wahab O, Dzik WH (2006). "Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature". Transfusion. 46 (5): 741–53. doi:10.1111/j.1537-2995.2006.00792.x. PMID 16686841.